0001193125-16-737636.txt : 20161114 0001193125-16-737636.hdr.sgml : 20161111 20161013154302 ACCESSION NUMBER: 0001193125-16-737636 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20161013 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cerulean Pharma Inc. CENTRAL INDEX KEY: 0001401914 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 204139823 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 35 GATEHOUSE DRIVE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-996-4300 MAIL ADDRESS: STREET 1: 35 GATEHOUSE DRIVE CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc DATE OF NAME CHANGE: 20070604 CORRESP 1 filename1.htm Acceleration Request

CERULEAN PHARMA INC.

35 GATEHOUSE DRIVE

WALTHAM, MA 02451

October 13, 2016

Via EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Re: Cerulean Pharma Inc.
Registration Statement on Form S-3
File No. 333-206396
Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Cerulean Pharma Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-206396) (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern time on October 14, 2016, or as soon thereafter as practicable.

[The remainder of this page is intentionally left blank.]

Very truly yours,
Cerulean Pharma Inc.
By:   /s/ Alejandra Carvajal
Name:   Alejandra Carvajal
Title:   Vice President and General Counsel

 

[Signature Page to Request for Acceleration]